SALZERH J F, SCHÄFER G, HOENIGL M, et al. Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis Jirovecii Pneumonia[J]. Respiration, 2018, 96(1): 52-65.
BUCHACZ K, LAU B, JING Y Z, et al. Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010[J]. The Journal of Infectious Diseases, 2016,214(6): 862-872.
DJAWE K, BUCHACZ K, HSU L, et al. Mortality Risk after AIDS-Defining Opportunistic Illness among HIV-Infected Persons—San Francisco, 1981-2012[J]. Journal of Infectious Diseases, 2015,212(9): 1366-1375.
LUNDBERGB E, DAVIDSON A J, BURMAN W J. Epidemiology of Pneumocystis Carinii Pneumonia in an Era of Effective Prophylaxis: The Relative Contribution of Non-adherence and Drug Failure[J]. AIDS, 2000, 14(16): 2559-2566.
钮正春, 施学忠. 123例艾滋病合并肺孢子菌肺炎的临床特点分析[J].河南医学研究, 2010, 19(3): 304-307.
马孝煜, 王敏, 刘纯.艾滋病合并肺孢子菌肺炎23例临床分析[J].中国感染控制杂志, 2015, 14(7): 459-463.
李凌华, 唐小平, 邓西龙, 等.艾滋病合并肺孢子菌肺炎69例临床分析[J].中华传染病杂志, 2008, 26(12): 739-743.
CILLÓNIZ C, DOMINEDÒ C, ÁLVAREZ-MARTÍNEZ M J, et al. Pneumocystis Pneumonia in the Twenty-first Century: HIV-infected Versus HIV-uninfected Patients[J]. Expert Review of Anti-Infective Therapy, 2019, 17(10): 787-801.
SIEGEL M, MASUR H, KOVACS J. Pneumocystis Jirovecii Pneumonia in Human Immunodeficiency Virus Infection[J]. Seminars in Respiratory and Critical Care Medicine, 2016, 37(2): 243-256.
CHOUKRI F, MENOTTI J, SARFATI C, et al. Quantification and SpreadofPneumocystis Jiroveciiin the Surrounding Air of Patients withPneumocystisPneumonia[J]. Clinical Infectious Diseases, 2010, 51(3): 259-265.
SHIBATA S, KIKUCHI T. Pneumocystis Pneumonia in HIV-1-infected Patients[J]. Respiratory Investigation, 2019, 57(3): 213-219.
ALANIO A, BRETAGNE S. Pneumocystis Jirovecii Detection in Asymptomatic Patients: What does Its Natural History Tell Us?[J]. F1000Research, 2017, 6: 739.
VASSALLO R, STANDING JE, LIMPER AH. Isolated Pneumocystis carinii Cell Wall Glucan Provokes Lower Respiratory Tract Inflammatory Responses[J]. The Journal of Immunology, 2000,164(7): 3755-3763.
杨迪虹, 徐媛, 宋周烨, 等.卡泊芬净用于肺孢子菌肺炎的临床研究进展[J].中国医院药学杂志, 2019, 39(5): 531-534.
何小清, 沈银忠.肺孢子菌肺炎诊治的研究进展[J].中国真菌学杂志, 2018, 13(4): 247-251.
TASAKA S. Recent Advances in the Diagnosis and Management of Pneumocystis Pneumonia[J]. Tuberc Respir Dis (Seoul), 2020, 83(2): 132-140.
SELWYN PA, PUMERANTZ AS, DURANTE A, et al. Clinical Predictors of Pneumocystis Carinii Pneumonia, Bacterial Pneumonia and Tuberculosis inHIV-Infected Patients[J]. AIDS, 1998, 12(8): 885-893.
NG V L, YAJKO D M, HADLEY W K. Extrapulmonary Pneumocystosis[J]. ClinicalMicrobiologyReviews, 1997, 10(3): 401-418.
SCHILDGEN V, MAI S, KHALFAOUI S, et al. Pneumocystis Jirovecii Can Be Productively Cultured in Differentiated CuFi-8 Airway Cells[J]. mBio, 2014, 5(3): e01186-14.
WHITE P L, BACKX M, BARNES R A. Diagnosis and Management of Pneumocystis Jirovecii Infection[J]. Expert Review of Anti-InfectiveTherapy, 2017, 15(5): 435-447.
PROCOP G W, HADDAD S, QUINN J, et al. Detection of Pneumocystis Jiroveci in Respiratory Specimens by Four Staining Methods[J]. Journal of Clinical Microbiology, 2004, 42(7): 3333-3335.
FLORI P, BELLETE B, DURAND F, et al. Comparison between Real-time PCR, Conventional PCR and Different Staining Techniques for Diagnosing Pneumocystis Jiroveci Pneumonia from Bronchoalveolar Lavage Specimens[J]. Journal of Medical Microbiology, 2004, 53(7): 603-607.
ESTEVES F, LEE C H, DE SOUSA B, et al. (1-3)-Beta-D-glucan in Association with Lactate Dehydrogenase as Biomarkers of Pneumocystis Pneumonia (PcP) in HIV-infected Patients[J]. European Journal of Clinical Microbiology & Infectious Diseases, 2014, 33(7): 1173-1180.
HELD J, KOCH M S, REISCHL U, et al. Serum (1 → 3)-β-d-glucan Measurement as an Early Indicator of Pneumocystis Jirovecii Pneumonia and Evaluation of Its Prognostic Value[J]. ClinicalMicrobiologyand Infection, 2011, 17(4): 595-602.
TASAKA S, HASEGAWA N, KOBAYASHI S, et al. Serum Indicators for the Diagnosis of Pneumocystis Pneumonia[J]. Chest, 2007,131(4): 1173-1180.
NAKAMURA H, TATEYAMA M, TASATO D, et al. Clinical Utility of Serum β-D-Glucan and KL-6 Levels in Pneumocystis Jirovecii Pneumonia[J]. InternalMedicine, 2009, 48(4): 195-202.
VOGEL M N, WEISSGERBER P, GOEPPERT B, et al. Accuracy of Serum LDH Elevation for the Diagnosis of Pneumocystis Jiroveci Pneumonia[J]. Swiss MedicalWeekly, 2011,141: w13184.
ESTEVES F, CAL? S S, BADURA R, et al. Diagnosis of Pneumocystis Pneumonia: Evaluation of Four Serologic Biomarkers[J]. ClinicalMicrobiologyand Infection, 2015, 21(4): 379. e1-379. e10.
牟向东, 高莉, 王仁贵, 等.非艾滋病免疫抑制宿主肺孢子菌肺炎影像学特点及其与预后的关系[J].中华医学杂志, 2012, 92(38): 2703-2706.
LOGAN PM, FINNEGAN MM. Pulmonary Complications inAIDS: Ct Appearances[J]. Clin Radiol, 1998, 53(8): 567-573.
BOISELLE P M, TOCINO I, HOOLEY R J, et al. Chest Radiograph Interpretation of Pneumocystis Carinii Pneumonia, Bacterial Pneumonia, and Pulmonary Tuberculosis in Hiv-Positive Patients: Accuracy, Distinguishing Features, and Mimics[J]. J Thorac Imaging, 1997, 12(1): 47-53.
KUHLMAN J E. Pneumocystic Infections: The Radiologist's Perspective[J]. Radiology, 1996,198(3): 623-635.
DIEDERICH S. Chest Ct for Suspected Pulmonary Complications of Oncologic Therapies: How I Review and Report[J]. Cancer Imaging, 2016, 16: 7.
MU X D, JIA P, GAO L, et al. Relationship between Radiological Stages and Prognoses of Pneumocystis Pneumonia in Non-AIDS Immunocompromised Patients[J].中华医学杂志(英文版), 2016,129(17): 2020-2025.
吴迪, 谢红浪.肺孢子虫肺炎与巨细胞病毒肺炎影像学特点[J].肾脏病与透析肾移植杂志, 2010, 1(19): 66-70.
GRUDEN J F, HUANG L, TURNER J, et al. High-Resolution Ct in the Evaluation of Clinically Suspected Pneumocystis Carinii Pneumonia in AIDS Patients with Normal, Equivocal, or Nonspecific Radiographic Findings[J]. American Journal of Roentgenology, 1997,169(4): 967-975.
赵大伟, 张可, 马大庆, 等.艾滋病合并卡氏肺囊虫肺炎的影像学表现[J].中华放射学杂志, 2002, 4(36): 351-353.
BOISELLE P M, CRANS C A, KAPLAN M A. The Changing Face of Pneumocystis Carinii Pneumonia in AIDS Patients[J]. American Journal of Roentgenology, 1999,172(5): 1301-1309.
HARDAK E, BROOK O, YIGLA M. Radiological Features of Pneumocystis Jirovecii Pneumonia in Immunocompromised Patients with and without AIDS[J]. Lung, 2010,188(2): 159-163.
TOKUDA H, SAKAI F, YAMADA H, et al. Clinical and Radiological Features of Pneumocystis Pneumonia in Patients with Rheumatoid Arthritis, in Comparison with Methotrexate Pneumonitis and Pneumocystis Pneumonia in Acquired Immunodeficiency Syndrome: A Multicenter Study[J]. Internal medicine, 2008, 47(10): 915-923.
马胜江.艾滋病合并卡氏肺孢子菌肺炎的CT诊断[J].中国CT和MRI杂志, 2019, 7(17): 74-75,106.
MULTUM Cerner. Sulfamethoxazole and Trimethoprim Injection[EB/OL]. (2020-02-26)[2020-06-01]. http://Dailymed.Nlm.Nih.Gov/Dailymed/Druginfo.Cfm?Id=15491.
周祝娟.艾滋病和非艾滋病免疫功能抑制患者合并肺孢子菌肺炎临床分析[D].南昌: 南昌大学, 2018.http://cdmd.cnki.com.cn/Article/CDMD-10403-1018219747.htm
PONCEC A, CHABÉ M, GEORGE C, et al. High Prevalence of Pneumocystis Jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy[J]. Antimicrobial Agents and Chemotherapy, 2017, 61(2): AAC. 01290-16.
KOVACSJ A, MASUR H. Prophylaxis Against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection[J]. New England Journal of Medicine, 2000,342(19): 1416-1429.
MEDINA I, MILLS J, LEOUNG G, et al. Oral Therapy for Pneumocystis Carinii Pneumonia in the Acquired Immunodeficiency Syndrome. a Controlled Trial of Trimethoprim-Sulfamethoxazole Versus Trimethoprim-Dapsone[J]. The New England Journal of Medicine, 1990,323(12): 776-782.
SMEGO R A, NAGAR S, MALOBA B, et al. A Meta-Analysis of Salvage Therapy for Pneumocystis Carinii Pneumonia[J]. Archives of Internal Medicine, 2001,161(12): 1529-1533.
HELWEG-LARSEN J, BENFIELD T, ATZORI C, et al. Clinical Efficacy of First- and Second-Line Treatments forHIV-Associated Pneumocystis Jirovecii Pneumonia: A Tri-Centre Cohort Study[J]. The Journal of Antimicrobial Chemotherap, 2009, 64(6): 1282-1290.
ZHANG G, CHEN M, ZHANG S, et al. Efficacy ofCaspofungin Combined with Trimethoprim/Sulfamethoxazole as First-Line Therapy to Treat Non-HIV Patients with Severe Pneumocystis Pneumonia[J]. Experimental and Therapeutic Medicine, 2018, 15(2): 1594-1601.
WANG L, LIANG H, YE L, et al. Adjunctive Corticosteroids for the Treatment of PneumocystisJiroveci Pneumonia in Patients with HIV: A Meta-Analysis[J]. Experimental and Therapeutic Medicine, 2016, 11(2): 683-687.
CONFALONIERI M, CALDERINI E, TERRACIANO S, et al. Noninvasive Ventilation for Treating Acute Respiratory Failure inAIDS Patients with Pneumocystis Carinii Pneumonia[J]. Intensive Care Med, 2002, 28(9): 1233-1238.
SCHAFER G, HOFFMANN C, ARASTEH K, et al. Immediate Versus Deferred Antiretroviral Therapy inHIV-Infected Patients Presenting with Acute AIDS-Defining Events (Toxoplasmosis, Pneumocystis Jirovecii-Pneumonia): A Prospective, Randomized, Open-Label Multicenter Study (Ideal-Study)[J]. AIDS Research and Therapy, 2019, 16(1): 34.
SHELBURNE S A, MONTES M, HAMILL R J. Immune Reconstitution Inflammatory Syndrome: More Answers, More Questions[J]. Journal of Antimicrobial Chemotherapy, 2006, 57(2): 167-170.
LEOUNG G S, STANFORD J F, GIORDANO M F, et al. Trimethoprim-Sulfamethoxazole (Tmp-Smz) Dose Escalation Versus Direct Rechallenge for Pneumocystis Carinii Pneumonia Prophylaxis in Human Immunodeficiency Virus-Infected Patients with Previous Adverse Reaction to Tmp-Smz[J]. Journal of Infectious Diseases, 2001,184(8): 992-997.
STANSELL J D, OSMOND D H, CHARLEBOIS E, et al. Predictors of Pneumocystis Carinii Pneumonia in HIV-Infected Persons. Pulmonary Complications of HIV Infection Study Group[J]. American Journal of Respiratory & Critical Care Medicine, 1997,155(1): 60-66.
PIFER LL, HUGHES WT, STAGNO S, WOODS D. Pneumocystis Carinii Infection: Evidence for High Prevalence in Normal and Immunosuppressed Children[J]. Pediatrics, 1978, 61(1): 35-41.